Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 15th total of 12,100 shares. Based on an average trading volume of 124,300 shares, the short-interest ratio is presently 0.5 days.

Fresenius SE & Co. KGaA Stock Up 1.1 %

OTCMKTS:FSNUY traded up $0.10 on Wednesday, hitting $8.99. 120,195 shares of the company’s stock were exchanged, compared to its average volume of 126,849. The firm has a 50-day moving average price of $8.86 and a 200-day moving average price of $8.90. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. Fresenius SE & Co. KGaA has a 52 week low of $6.57 and a 52 week high of $9.78. The company has a market cap of $20.08 billion, a P/E ratio of 12.36 and a beta of 1.02.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a report on Friday, October 25th.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.